Key result
Heparin shows potential anti-cancer effects beyond anticoagulation in cancer-associated thrombosis.
Key points are not available for this paper at this time.
We enjoyed the recent articles on cancer-associated thrombosis and wish to comment on the attempts to explain the beneficial effects of heparin in cancer ( Noble and Pasi, 2010 ; Kakkar and Macbeth, 2010 ).
No takes yet. Share an insight, caveat, or question.
Solari et al. (2010) studied this question. Heparin may exert beneficial anti-cancer effects through mechanisms independent of its anticoagulant properties in patients with cancer-associated thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: